Australia - February 2025

On 9 February, the Australian government announced that it would invest AUD 573 million (approximately USD 361 million) in women’s health over five years, aimed at improving affordability and access to contraception and menopausal hormone therapy. The package of measures adds contraceptive pills to the pharmaceutical benefits scheme (PBS) for the first time in decades and reduces the costs of menopause treatment. The government estimates these measures could save up to 300,000 Australian women around AUD 400 annually in out-of-pocket expenses for birth control devices like intrauterine devices (IUDs). Those undergoing menopause treatment could save up to AUD 290 annually – or AUD 577 for pensioners or low-income individuals. Health experts and women’s rights advocates have praised the package as a significant step toward a more equitable healthcare system. The announcement follows extensive consultations with women, healthcare providers and advocacy groups and is informed by the findings of two separate Senate inquiries.

Sources: The Guardian, Commonwealth of Australia, The University of Melbourne